Vera Health Secures $28.5 Million to Scale Clinical Tool
The platform plans to expand its evidence-based search engine and hire internationally following a successful funding round.
Updated on Oct. 27, 2026 in Healthcare
Live Poll
Would you use an AI-driven search engine to help assess clinical research at the point of care?
Vera Health has raised $28.5 million in a Series A funding round to scale its clinical search platform. The company, which provides evidence-based medical information, intends to use the capital to grow its team and expand international operations.
Why it matters
The investment enables Vera Health to build out its proprietary evidence infrastructure at a time when medical professionals are increasingly relying on AI-driven search tools to verify clinical guidelines.
Vera Health secured $28.5 million in Series A funding, marking a significant increase from its prior $3.5 million total capital raised. The platform currently supports 800,000 clinicians across 190 countries by indexing over 60 million peer-reviewed medical publications.
The players
Vera Health
An early-stage medical technology firm that provides a clinical search engine for healthcare professionals.
Threshold Ventures
A venture capital firm focused on investing in early-stage technology companies.
The details
The platform functions by scanning a massive repository of clinical guidelines, consensus statements, and drug labels to synthesize verifiable medical answers. Unlike general-purpose AI, the system prioritizes existing evidence verification before generating responses to ensure clinical accuracy. Adoption has been primarily driven by professional peer referrals, helping the firm reach its current scale with a lean team of 12 employees.
Timeline
June 2026: Vera became the most downloaded clinical app monthly.
October 27, 2026: The company announced its Series A funding round.
Market Landscape
This investment follows an industry-wide trend of venture capital supporting specialized search tools that prioritize verifiable evidence over general-purpose generative AI. It positions Vera Health alongside other entities racing to capture the market for clinical decision-support software.
Operators in the health-tech space should monitor the company's planned international expansion and team growth, which signal a move toward more traditional sales operations. The reliance on clinician referrals rather than sales forces serves as a benchmark for user-acquisition efficiency.
The takeaway
Vera Health demonstrates that product-led growth through clinician referrals can successfully scale a niche search tool to a global user base. Leaders should track how the firm balances this organic growth with its new mandate for team expansion and formal partnerships.
Further reading
For broader trends in medical software, visit Healthcare.
Live Poll
Would you use an AI-driven search engine to help assess clinical research at the point of care?
